Wilson Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Wilson Disease Pipeline Drugs Market Report Overview
Wilson disease is a rare autosomal recessive inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues. Symptoms include abdominal pain, jaundice, problems with speech and swallowing, and muscle stiffness. Treatment includes chelators and Vitamin E supplements.
The Wilson disease pipeline market research report provides comprehensive information on the therapeutics under development for Wilson disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Wilson disease and features dormant and discontinued projects.
Wilson Disease Pipeline Products Market Segmentation by Targets
The key targets in the Wilson disease pipeline products market are Copper Transporting ATPase 2, Copper, Superoxide Dismutase [Cu-Zn], and Tyrosine Protein Phosphatase Non Receptor Type 1. Copper Transporting ATPase 2 is the leading target in the pipeline.
Wilson Disease Pipeline Products Market Analysis by Targets
For more target insights into the Wilson disease pipeline products market, download a free report sample
Wilson Disease Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Wilson disease pipeline products market are Copper Transporting ATPase 2 Activator, Copper Chelator, Superoxide Dismutase [Cu-Zn] Inhibitor, and Tyrosine Protein Phosphatase Non Receptor Type 1 Inhibitor. Copper Transporting ATPase 2 Activator is the leading MoA in the pipeline market.
Wilson Disease Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Wilson disease pipeline products market, download a free report sample
Wilson Disease Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Wilson disease pipeline products market are oral and intravenous. Both have an equal number of products in the pipeline.
Wilson Disease Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights into the Wilson disease pipeline products market, download a free report sample
Wilson Disease Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Wilson disease pipeline products market are gene therapy, small molecule, antisense oligonucleotide, gene-modified cell therapy, and peptide. The leading molecule type is gene therapy.
Wilson Disease Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Wilson disease pipeline products market, download a free report sample
Wilson Disease Pipeline Products Market - Competitive Landscape
Some of the leading companies in the Wilson disease pipeline products market are Vivet Therapeutics SAS, Alexion Pharmaceuticals Inc, ARBORMED Pharmaceuticals Inc, Deep Genomics Inc, DepYmed Inc, Enveda Biosciences Inc, Generation Bio Co, and Krisani Bio Sciences Pvt Ltd among others. Vivet Therapeutics SAS is the leading company in the Wilson disease pipeline products market.
Wilson Disease Pipeline Products Market Analysis by Companies
To know more about the leading players in the Wilson disease pipeline products market, download a free report sample
Wilson Disease Pipeline Products Market Report Overview
Key Targets | Copper Transporting ATPase 2, Copper, Superoxide Dismutase [Cu-Zn], and Tyrosine Protein Phosphatase Non Receptor Type 1 |
Key Mechanisms of Action | Copper Transporting ATPase 2 Activator, Copper Chelator, Superoxide Dismutase [Cu-Zn] Inhibitor, and Tyrosine Protein Phosphatase Non Receptor Type 1 Inhibitor |
Key Routes of Administration | Oral and Intravenous |
Key Molecule Type | Gene Therapy, Small Molecule, Antisense Oligonucleotide, Gene-Modified Cell Therapy, and Peptide |
Leading Companies | Vivet Therapeutics SAS, Alexion Pharmaceuticals Inc, ARBORMED Pharmaceuticals Inc, Deep Genomics Inc, DepYmed Inc, Enveda Biosciences Inc, Generation Bio Co, and Krisani Bio Sciences Pvt Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Wilson disease.
- The pipeline guide reviews pipeline therapeutics for Wilson disease by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Wilson disease therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Wilson disease therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Wilson disease
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Wilson disease.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the Wilson disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
ARBORMED Pharmaceuticals Inc
Deep Genomics Inc
DepYmed Inc
Enveda Biosciences Inc
Generation Bio Co
Krisani Bio Sciences Pvt Ltd
LambdaGen Therapeutics
Logicbio Therapeutics Inc
MeiraGTx Holdings Plc
Shanghai Pharmaceuticals Holding Co Ltd
Ultragenyx Pharmaceutical Inc
Vivet Therapeutics SAS
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Wilson disease pipeline products market?
The key targets in the Wilson disease pipeline products market are Copper Transporting ATPase 2, Copper, Superoxide Dismutase [Cu-Zn], and Tyrosine Protein Phosphatase Non Receptor Type 1.
-
What are the key mechanisms of action in the Wilson disease pipeline products market?
The key mechanisms of action in the Wilson disease pipeline products market are Copper Transporting ATPase 2 Activator, Copper Chelator, Superoxide Dismutase [Cu-Zn] Inhibitor, and Tyrosine Protein Phosphatase Non Receptor Type 1 Inhibitor.
-
What are the key routes of administration in the Wilson disease pipeline products market?
The key routes of administration in the Wilson disease pipeline products market are oral and intravenous.
-
What are the key molecule types in the Wilson disease pipeline products market?
The key molecule types in the Wilson disease pipeline products market are gene therapy, small molecule, antisense oligonucleotide, gene-modified cell therapy, and peptide.
-
Which are the leading companies in the Wilson disease pipeline products market?
Some of the leading companies in the Wilson disease pipeline products market are Vivet Therapeutics SAS, Alexion Pharmaceuticals Inc, ARBORMED Pharmaceuticals Inc, Deep Genomics Inc, DepYmed Inc, Enveda Biosciences Inc, Generation Bio Co, and Krisani Bio Sciences Pvt Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.